ADAR1 Capital Management »

Kohl's Corporation shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Kohl's Corporation (KSS) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Kohl's Corporation

Tip: Access up to 7 years of quarterly data

All positions including Kohl's Corporation held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kohl's Corporation by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $57k 2.0k 28.68

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Roivant Sciences SHS (ROIV)
Cytokinetics Com New (CYTK)
Arbutus Biopharma (ABUS)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Cerevel Therapeutics Hldng I (CERE)
Mirati Therapeutics
Merck & Co (MRK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Immunovant (IMVT)
Viking Therapeutics (VKTX)
Protagonist Therapeutics (PTGX)

View all positions for ADAR1 Capital Management

Top funds holding Kohl's Corporation

Vanguard Group
T. Rowe Price Associates
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
LSV Asset Management
Barclays
Susquehanna International
Allianz Asset Management
Citadel Advisors
Ancora Advisors
Two Sigma Investments
Bank of America Corporation
Voloridge Investment Management
Bank of New York Mellon
Charles Schwab Investment Management

View all funds holding Kohl's Corporation